ConductScience.org, home

Paper42957232PubMed

Complete Response Demonstrated by [11C]methionine-PET Imaging of a Patient With Squamous-cell Carcinoma of the Tongue Treated With Chemotherapy, Immunotherapy and Methionine Restriction Without Radiation or Surgery: A Potential New Low-toxicity Treatment Paradigm for a Recalcitrant Disease.

Ishiguro T and 8 others. In Vivo, 2026.

Cite this record

ConductScience Library. Complete Response Demonstrated by [11C]methionine-PET Imaging of a Patient With Squamous-cell Carcinoma of the Tongue Treated With Chemotherapy, Immunotherapy and Methionine Restriction Without Radiation or Surgery: A Potential New Low-toxicity Treatment Paradigm for a Recalcitrant Disease. Papers, record 42957232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42957232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Complete Response Demonstrated by [11C]methionine-PET Imaging of a Patient With Squamous-cell Carcinoma of the Tongue Treated With Chemotherapy, Immunotherapy and Methionine Restriction Without Radiation or Surgery: A Potential New Low-toxicity Treatment Paradigm for a Recalcitrant Disease.
Journal
In Vivo
Year
2026
Publication types
Journal Article, Case Reports
Revised in PubMed
2026-11-03

Source PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ishiguro TTomoyuki
2Sato TToshihiko
3Han QQinghong
4Li SShukuan
5Miyashi YYuta
6Kang BMByung Mo
7Song SYTS Y Thomas
8Tsunoda TTakuya
9Hoffman RMRobert M

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MethionineMajor topic
Tongue NeoplasmsMajor topic
Carcinoma, Squamous CellMajor topic
Positron-Emission TomographyMajor topic
Humans
Middle Aged
Male
Immunotherapy
Treatment Outcome
Pathologic Complete Response
Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy

Source PubMed

Download CSV of topics

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
142746398Direct comparison of serine restriction on the viability of normal and cancer cells demonstrates that methionine restriction is more cancer specific.Front Oncol2026https://conductscience.org/library/papers/42746398PubMed
232276408Methionine Dependence of Cancer.Biomolecules2020https://conductscience.org/library/papers/32276408PubMed
342078309Chemotherapy in Combination With Methionine Restriction Induced A Complete Response in a Patient With Recurrent Metastatic Tongue Squamous-Cell Carcinoma.Cancer Diagn Progn2026https://conductscience.org/library/papers/42078309PubMed
437367741Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma.Med Sci (Basel)2023https://conductscience.org/library/papers/37367741PubMed
538522008Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments.Cancer Rep (Hoboken)2024https://conductscience.org/library/papers/38522008PubMed
66261250Reversible growth arrest in simian virus 40-transformed human fibroblasts.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6261250PubMed
722677908Dietary methyl donor depletion protects against intestinal tumorigenesis in Apc(Min/+) mice.Cancer Prev Res (Phila)2012https://conductscience.org/library/papers/22677908PubMed
813638009Quantitative nutritional studies with water-soluble, chemically defined diets. VIII. The forced feeding of diets each lacking in one essential amino acid.Arch Biochem Biophys1959https://conductscience.org/library/papers/13638009PubMed
95230235Methylation of nucleic acids in normal and leukemic leukocytes.Biochim Biophys Acta1966https://conductscience.org/library/papers/5230235PubMed
1029928962Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer.Cancer Lett2018https://conductscience.org/library/papers/29928962PubMed
1141318119FDG- and MET-PET Imaging Reveal Glucose and Methionine Addiction in a Primary Endometrial Cancer and Methionine Addiction only in a Para-aortic Lymph-node Metastasis in a 58-year-old Patient.Anticancer Res2025https://conductscience.org/library/papers/41318119PubMed
126661235The metabolic defect of methionine dependence occurs frequently in human tumor cell lines.Biochem Biophys Res Commun1983https://conductscience.org/library/papers/6661235PubMed
136937240Effect of nutritional and enzymatic methionine deprivation upon human normal and malignant cells in tissue culture.Cancer Res1980https://conductscience.org/library/papers/6937240PubMed
1436768257Superiority of [11C]methionine over [18F]deoxyglucose for PET Imaging of Multiple Cancer Types Due to the Methionine Addiction of Cancer.Int J Mol Sci2023https://conductscience.org/library/papers/36768257PubMed
156500606Elevated overall rates of transmethylation in cell lines from diverse human tumors.In Vitro1984https://conductscience.org/library/papers/6500606PubMed
163457200Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect.J Natl Cancer Inst1986https://conductscience.org/library/papers/3457200PubMed
1735434545Linkage of methionine addiction, histone lysine hypermethylation, and malignancy.iScience2022https://conductscience.org/library/papers/35434545PubMed
1841438985Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase, and have increased c-MYC expression.Front Oncol2025https://conductscience.org/library/papers/41438985PubMed
1938572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
202213904Methionine dependency of malignant tumors: a possible approach for therapy.J Natl Cancer Inst1990https://conductscience.org/library/papers/2213904PubMed

See all 55 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42957232

GET https://conductscience.org/api/papers/v1/42957232/references?page=2